EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nucleic Acid‐Modified Nanoparticles for Cancer Therapeutic Applications

Yunlong Qin, Xinghua Chen, Itamar Willner iD

Small · 2025-07 · 21 (27)

DOI: 10.1002/smll.202500843 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 27.05.2025. Verfasst von Yunlong Qin und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, 91904, Israel. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles, Nucleic Acids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanomaterials including metal or metal oxide nanoparticles, carbonous nanomaterial (e.g., carbon dots) or metal–organic framework nanoparticles provide porous, catalytically active surfaces and functional interfaces for binding of ions or molecular agents. By the conjugation of nucleic acids to the nanoparticles, hybrid nanostructures revealing emerging multimodal catalytic/photocatalytic activities, high loading capacities, and effective targeted cell permeation efficacies are formed. The review article exemplifies the application of nucleic acid‐modified nanoparticles conjugates for therapeutic treatment of cancer cells. Stimuli‐responsive reconfiguration of nucleic acid strands and the specific recognition and catalytic function of oligonucleotides associated with porous, catalytic, and photocatalytic nanoparticles yield hybrid composites demonstrating cooperative synergistic properties for medical applications. The targeted chemodynamic, photodynamic, photothermal and chemotherapeutic treatment of cancer cells by the oligonucleotide/nanoparticle conjugates is addressed. In addition, the application of oligonucleotide/nanoparticle conjugates for gene therapy treatment of cancer cells is discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesNucleic AcidsHumansAnimalsGenetic Therapy

Stichwörter der Autor:innen

DNAzymesG‐quadruplexesaptamerschemodynamicgene therapyphotodynamicphotothermal

Substanzen

Nucleic Acids

Autor:innen und Institutionen

  • The Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, 91904, Israel.

ORCID-Profile: Itamar Willner

Förderung

  • Israel Ministry of Health

Zitieren

APA

Qin, Y., Chen, X., & Willner, I. (2025). Nucleic Acid‐Modified Nanoparticles for Cancer Therapeutic Applications. Small, 21(27). https://doi.org/10.1002/smll.202500843

Vancouver

Qin Y, Chen X, Willner I. Nucleic Acid‐Modified Nanoparticles for Cancer Therapeutic Applications. Small. 2025;21(27). doi:10.1002/smll.202500843

BibTeX
@article{Qin2025,
  author = {Qin, Yunlong and Chen, Xinghua and Willner, Itamar},
  title = {Nucleic Acid‐Modified Nanoparticles for Cancer Therapeutic Applications},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {27},
  doi = {10.1002/smll.202500843}
}
Kostenlos starten →